Pranita Atri
University of Nebraska Medical Center
H-index: 13
North America-United States
Top articles of Pranita Atri
Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma
npj Precision Oncology
2024/3/7
Mucins as potential biomarkers for early detection of cancer
2023/3/7
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
Cell reports
2023/2/28
Distinct tumor architectures for metastatic colonization of the brain
bioRxiv
2023/1/28
A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research
2023/9/15
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR
Breast Cancer Research
2023/3/14
Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma
Cancer letters
2022/12/28
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma
Oncogene
2022/11/25
Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer
2022/11/1
MUC16 promotes liver metastasis of pancreatic ductal adenocarcinoma by upregulating NRP2-associated cell adhesion
Molecular Cancer Research
2022/8/5
A novel role of MUC5AC/CD44v6/c-Met axis in breast cancer brain metastasis
Cancer Research
2022/6/15
MicroRNA-1 targets CXCR4/FOXM1/RRM2 axis regulating small cell lung cancer growth and metastasis
Cancer Research
2022/6/15
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Molecular cancer therapeutics
2022/4/1
Repressing ABCB7 Potentiates Cisplatin Response in Pediatric Group 3 Medulloblastoma by Triggering Ferroptosis
bioRxiv
2022/1/25
Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma
American Journal of Cancer Research
2022
Sugandha Saxena
H-Index: 8
Dipakkumar R Prajapati
H-Index: 3
Pranita Atri
H-Index: 7
Sukhwinder Kaur
H-Index: 33
Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling
EBioMedicine
2022/1/1
Parthasarathy Seshacharyulu
H-Index: 22
Ramakrishna Nimmakayala
H-Index: 8
Sanjib Chaudhary
H-Index: 9
Pranita Atri
H-Index: 7
Joseph Carmicheal
H-Index: 5
Raghupathy Vengoji
H-Index: 8
Shuo Wang
H-Index: 31
Lynette Smith
H-Index: 44
Sukhwinder Kaur
H-Index: 33
Sushil Kumar
H-Index: 4
Maneesh Jain
H-Index: 33
Chi Lin
H-Index: 15
Mucin 5ac serves as the nexus for β-catenin/c-myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance
Gastroenterology
2022/1/1
Protein phosphatase 2A as a therapeutic target in small cell lung cancer
Molecular cancer therapeutics
2021/10/1
Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring
Cancer letters
2021/7/10
ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation
Molecular Oncology
2021/7
